US2009158470A1PendingUtilityA1

Compositions and methods for the treatment of Pierce's Disease

Assignee: GUPTA GOUTAMPriority: May 14, 2004Filed: Oct 7, 2008Published: Jun 18, 2009
Est. expiryMay 14, 2024(expired)· nominal 20-yr term from priority
Inventors:Goutam Gupta
C12N 15/8281C07K 14/43563C07K 2319/00C07K 14/4723
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Chimeric anti-microbial proteins, compositions, and methods for the therapeutic and prophylactic treatment of plant diseases caused by the bacterial pathogen Xylella fastidiosa are provided. The anti-microbial proteins of the invention generally comprise a surface recognition domain polypeptide, capable of binding to a bacterial membrane component, fused to a bacterial lysis domain polypeptide, capable of affecting lysis or rupture of the bacterial membrane, typically via a fused polypeptide linker. In particular, methods and compositions for the treatment or prevention of Pierce's disease of grapevines are provided. Methods for the generation of transgenic Vitus vinefera plants expressing xylem-secreted anti-microbial chimeras are also provided.

Claims

exact text as granted — not AI-modified
1 . A chimeric anti-microbial protein comprising a surface recognition domain physically linked to an insect cecropin. 
     
     
         2 . The chimeric anti-microbial protein of  claim 1 , wherein the insect cecropin is cecropin A. 
     
     
         3 . The chimeric anti-microbial protein of  claim 1 , wherein the insect cecropin is cecropin B. 
     
     
         4 . The chimeric anti-microbial protein of  claim 3 , wherein the surface recognition domain is human neutrophil elastase or an active fragment thereof. 
     
     
         5 . The chimeric anti-microbial protein of  claim 4 , wherein the C-terminus of the surface recognition domain is physically linked to the N-terminus of insect cecropin B by a fused polypeptide linker of between 2 and 20 amino acid residues. 
     
     
         6 . The chimeric anti-microbial protein of  claim 5 , having an amino acid sequence selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 3. 
     
     
         7 . An isolated nucleic acid molecule encoding a chimeric anti-microbial protein according to  claim 6 . 
     
     
         8 . An expression vector comprising the nucleic acid molecule of  claim 7 . 
     
     
         9 . A cell comprising the expression vector of  claim 8 . 
     
     
         10 . A method of producing a chimeric anti-microbial protein according to  claim 6 , comprising:
 (a) providing an expression vector according to  claim 8 ,   (b) transforming or transfecting a suitable host cell with the expression vector,   (c) expressing the chimeric anti-microbial protein encoded by the expression vector.   
     
     
         11 . An isolated nucleic acid molecule encoding a chimeric anti-microbial protein according to  claim 5 , the chimeric anti-microbial protein further containing a fused N-terminal xylem secretory leader. 
     
     
         12 . An isolated nucleic acid molecule according to  claim 11 , wherein the N-terminal xylem secretory leader is selected from the group consisting of SEQ ID NO: 6 and SEQ ID NO: 7. 
     
     
         13 . An expression vector comprising the nucleic acid molecule of  claim 12 . 
     
     
         14 . A cell comprising the expression vector of  claim 13 . 
     
     
         15 . A  Vitus vinifera  cell comprising the expression vector of  claim 13 . 
     
     
         16 . A transgenic  Vitus vinifera  plant comprising the expression vector of  claim 13 . 
     
     
         17 . A method of treating Pierce's Disease in a  Vitus vinifera  plant infected with Xf, comprising introducing a chimeric anti-microbial protein according to  claim 5  into the xylem of the infected  Vitus vinifera  plant. 
     
     
         18 . A method of treating Pierce's Disease in a  Vitus vinifera  plant infected with Xf, comprising contacting Xf cells present in the infected plant with a chimeric anti-microbial protein according to  claim 5 . 
     
     
         19 . A method of treating Pierce's Disease in a  Vitus vinifera  plant infected with Xf, comprising spraying the  Vitus vinifera  plant with an adherent composition containing a chimeric anti-microbial protein according to  claim 5 . 
     
     
         20 . A method of preventing the development of Pierce's Disease in a  Vitus vinifera  plant, comprising spraying the  Vitus vinifera  plant with an adherent composition containing a chimeric anti-microbial protein according to  claim 5 . 
     
     
         21 . A method of inhibiting the spread of Pierce's Disease, comprising introducing a chimeric anti-microbial protein according to  claim 5  into a glassy-winged sharpshooter insect vector of Xf. 
     
     
         22 . The method according to  claim 19 , wherein the chimeric anti-microbial protein is introduced into the glassy-winged sharpshooter insect by feeding the insect a composition containing the chimeric anti-microbial protein.

Join the waitlist — get patent alerts

Track US2009158470A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.